| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 1289 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 1289 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1289 |
| 3 | METHOTREXATE SODIUM | 976 |
| 4 | METHOTREXATE | 909 |
| 5 | BUSULFAN | 888 |
| 6 | FLUDARABINE PHOSPHATE | 865 |
| 7 | CYTARABINE | 707 |
| 8 | TACROLIMUS | 671 |
| 9 | ETOPOSIDE | 636 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETIBEGLOGENE AUTOTEMCEL | 8 | 0.1429 |
| 1 | DYCLONINE HCL, MENTHOL, AND PECTIN | 1 | 0.1111 |
| 2 | DEFIBROTIDE SODIUM | 347 | 0.0968 |
| 3 | INOTUZUMAB OZOGAMICIN | 260 | 0.0869 |
| 4 | GEMTUZUMAB OZOGAMICIN | 260 | 0.0709 |
| 5 | BUSULFAN | 888 | 0.0558 |
| 6 | THIOTEPA | 416 | 0.0426 |
| 7 | EXAGAMGLOGENE AUTOTEMCEL | 2 | 0.0400 |
| 8 | DACTINOMYCIN | 77 | 0.0348 |
| 9 | TREOSULFAN | 95 | 0.0344 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 1939 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1165 |
| 2 | Corticosteroid [EPC] | 920 |
| 3 | Platinum-based Drug [EPC] | 911 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 910 |
| 5 | Topoisomerase Inhibitor [EPC] | 642 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 445 |
| 7 | Azole Antifungal [EPC] | 384 |
| 8 | Bile Acid [EPC] | 295 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 287 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 260 | 0.0869 |
| 1 | CD33-directed Immunoconjugate [EPC] | 260 | 0.0709 |
| 2 | Actinomycin [EPC] | 77 | 0.0348 |
| 3 | Hematopoietic Stem Cell Mobilizer [EPC] | 34 | 0.0229 |
| 4 | Bile Acid [EPC] | 295 | 0.0128 |
| 5 | Asparagine-specific Enzyme [EPC] | 147 | 0.0109 |
| 6 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 4 | 0.0103 |
| 7 | Echinocandin Antifungal [EPC] | 74 | 0.0090 |
| 8 | Topoisomerase Inhibitor [EPC] | 642 | 0.0083 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 27 | 0.0083 |